Auswahl der wissenschaftlichen Literatur zum Thema „LysoPAF“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "LysoPAF" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "LysoPAF"
Chai, Yuh-Cherng, David G. Binion und Guy M. Chisolm. „Relationship of molecular structure to the mechanism of lysophospholipid-induced smooth muscle cell proliferation“. American Journal of Physiology-Heart and Circulatory Physiology 279, Nr. 4 (01.10.2000): H1830—H1838. http://dx.doi.org/10.1152/ajpheart.2000.279.4.h1830.
Der volle Inhalt der QuelleBakken, A. M., und M. Farstad. „The activities of acyl-CoA:1-acyl-lysophospholipid acyltransferase(s) in human platelets“. Biochemical Journal 288, Nr. 3 (15.12.1992): 763–70. http://dx.doi.org/10.1042/bj2880763.
Der volle Inhalt der QuelleSchindler, Peter W., und Ewa Ninio. „Kinetic studies of human and rat neutrophil lysoPAF acetyltransferase using lysoPAF and dansyllysoPAF as substrates“. Lipids 26, Nr. 12 (Dezember 1991): 1004–10. http://dx.doi.org/10.1007/bf02536492.
Der volle Inhalt der QuelleThumser, A. E., J. E. Voysey und D. C. Wilton. „The binding of lysophospholipids to rat liver fatty acid-binding protein and albumin“. Biochemical Journal 301, Nr. 3 (01.08.1994): 801–6. http://dx.doi.org/10.1042/bj3010801.
Der volle Inhalt der QuelleNAGUMO, Seiji, Akira FUKUJU, Mitsue TAKAYAMA, Masahiro NAGAI, Ryohei YANOSHITA und Yuji SAMEJIMA. „Inhibition of LysoPAF Acetyltransferase Activity by Components of Licorice Root.“ Biological & Pharmaceutical Bulletin 22, Nr. 10 (1999): 1144–46. http://dx.doi.org/10.1248/bpb.22.1144.
Der volle Inhalt der QuelleAoyama, Chieko, Hiroyuki Sugimoto, Hiromi Ando, Satoko Yamashita, Yasuhiro Horibata, Sayaka Sugimoto und Motoyasu Satou. „The heterotrimeric G protein subunits Gαq and Gβ1 have lysophospholipase D activity“. Biochemical Journal 440, Nr. 2 (14.11.2011): 241–50. http://dx.doi.org/10.1042/bj20110545.
Der volle Inhalt der QuelleGuimbaud, Rosine, Angelo Izzo, Jean Pierre Martinolle, Nicole Vidon, Daniel Couturier, Jacques Benveniste und Stanislas Chaussade. „Intraluminal excretion of PAF, lysoPAF, and acetylhydrolase in patients with ulcerative colitis“. Digestive Diseases and Sciences 40, Nr. 12 (Dezember 1995): 2635–40. http://dx.doi.org/10.1007/bf02220453.
Der volle Inhalt der QuelleChristman, B. W., J. W. Christman, R. Dworski, I. A. Blair und C. Prakash. „Prostaglandin E2 limits arachidonic acid availability and inhibits leukotriene B4 synthesis in rat alveolar macrophages by a nonphospholipase A2 mechanism.“ Journal of Immunology 151, Nr. 4 (15.08.1993): 2096–104. http://dx.doi.org/10.4049/jimmunol.151.4.2096.
Der volle Inhalt der QuellePetsini, Filio, Agathi Ntzouvani, Maria Detopoulou, Vasiliki D. Papakonstantinou, Nick Kalogeropoulos, Elizabeth Fragopoulou, Tzortzis Nomikos, Meropi D. Kontogianni und Smaragdi Antonopoulou. „Consumption of Farmed Fish, Fed with an Olive-Pomace Enriched Diet, and Its Effect on the Inflammatory, Redox, and Platelet-Activating Factor Enzyme Profile of Apparently Healthy Adults: A Double-Blind Randomized Crossover Trial“. Foods 11, Nr. 14 (15.07.2022): 2105. http://dx.doi.org/10.3390/foods11142105.
Der volle Inhalt der QuelleNoris, Marina, Daniela Macconi, Vittorio Nanni, Mario Salmona, Marta Todeschini und Giuseppe Remuzzi. „Defective glomerular [3H]lysoPAF metabolism in the autologous phase of rabbit nephrotoxic nephritis“. Kidney International 44, Nr. 4 (Oktober 1993): 747–54. http://dx.doi.org/10.1038/ki.1993.309.
Der volle Inhalt der QuelleDissertationen zum Thema "LysoPAF"
Stephenson, J. „Studies on molecular cloning of the genes for the enzymes #alpha#-L-iduronidase and arylsulphatase A“. Thesis, Open University, 1988. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.232964.
Der volle Inhalt der QuelleVaradarajan, Shankar. „P38 MAPKs coordinately regulate distinct phases of autophagy and lysomal biogenesis“. 2008. http://hdl.handle.net/2152/17812.
Der volle Inhalt der Quelletext
Prodoehl, Mark. „Functional analysis of the deubiquitylating enzyme fat facets in mouse in protein trafficking“. Thesis, 2008. http://hdl.handle.net/2440/49145.
Der volle Inhalt der QuelleThesis (Ph.D.) -- University of Adelaide, School of Molecular and Biomedical Sciences, 2008
Prodoehl, Mark. „Functional analysis of the deubiquitylating enzyme fat facets in mouse in protein trafficking“. 2008. http://hdl.handle.net/2440/49145.
Der volle Inhalt der QuelleThesis (Ph.D.) -- University of Adelaide, School of Molecular and Biomedical Sciences, 2008
Conway, Betsy Ann. „The effects of laforin, malin, Stbd1, and Ptg deficiencies on heart glycogen levels in Pompe disease mouse models“. Thesis, 2015. http://hdl.handle.net/1805/7979.
Der volle Inhalt der QuellePompe disease (PD) is a rare metabolic myopathy characterized by loss of acid alpha-glucosidase (GAA), the enzyme responsible for breaking down glycogen to glucose within the lysosomes. PD cells accumulate massive quantities of glycogen within their lysosomes, and as such, PD is classified as a “lysosomal storage disease” (LSD). GAA-deficient cells also exhibit accumulation of autophagic debris. Symptoms of severe infantile PD include extreme muscle weakness, hypotonia, and hypertrophic cardiomyopathy, resulting in death before one year of age. Certain LSDs are currently being successfully treated with enzyme replacement therapy (ERT), which involves intravenous infusion of a recombinant enzyme to counteract the endogenous deficiency. ERT has been less successful in PD, however, due to ineffective delivery of the recombinant enzyme. Alternatively, specific genes deletion may reduce lysosomal glycogen load, and could thus be targeted in PD therapy development. Absence of malin (EPM2B) or laforin (EPM2A) has been proposed to impair autophagy, which could reduce lysosomal glycogen levels. Additionally, deficiency of Stbd1 has been postulated to disable lysosomal glycogen import. Furthermore, Ptg deficiency was previously reported to abrogate Lafora body formation and correct neurological abnormalities in Lafora disease mouse models and could have similar effects on PD pathologies. The goal of this study was to characterize the effects of homozygous disruption of Epm2a, Epm2b, Stbd1, and Ptg loci on total glycogen levels in PD mouse model heart tissue, as in severe infantile PD, it is accumulation of glycogen in the heart that results in fatal hypertrophic cardiomyopathy. Gaa-/- mice were intercrossed with Epm2a-/-, Epm2b-/-, Stbd1-/-, and Ptg-/- mice to generate wildtype (WT), single knockout, and double knockout mice. The results indicated that Gaa-/- hearts accumulated up to 100-fold more glycogen than the WT. These mice also displayed cardiac hypertrophy. However, deficiency of Epm2a, Epm2b, Stbd1, or PTG in the Gaa-/- background did not reveal changes of statistical significance in either heart glycogen or cardiac hypertrophy. Nevertheless, since total glycogen was measured, these deficiencies should not be discarded in future discussions of PD therapy, as increasing sample sizes and/or distinguishing cytosolic from lysosomal glycogen content may yet reveal differences of greater significance.
Bücher zum Thema "LysoPAF"
Dice, J. Fred. Lysomal Pathways of Protein Degradation. Landes Bioscience, 2000.
Den vollen Inhalt der Quelle findenBuchteile zum Thema "LysoPAF"
Cataldo, Anne M., Deborah J. Hamilton, Jody L. Barnett, Peter A. Paskevich und Ralph A. Nixon. „Abnormalities of the Endosomal-Lysomal System in Alzheimer’s disease“. In Intracellular Protein Catabolism, 271–80. Boston, MA: Springer US, 1996. http://dx.doi.org/10.1007/978-1-4613-0335-0_34.
Der volle Inhalt der QuelleSchindler, Peter, und Ewa Ninio. „Kinetic Studies of Human and Rat Neutrophil LysoPAF Acetyltransferase Using LysoPAF and DansyllysoPAF as Substrates“. In Platelet-Activating Factor and Structurally Related Alkyl Ehter Lipids, 1004–10. AOCS Publishing, 1992. http://dx.doi.org/10.1201/9781439832042.ch8.
Der volle Inhalt der QuelleDoebber, Thomas, Margaret Wu, Anthony Mauriello und Alfred Alberts. „Platelet-Activating Factor (PAF) Stimulates the LysoPAF Acetyltransferase in Leukocyte-Rich Plasma“. In Platelet-Activating Factor and Structurally Related Alkyl Ehter Lipids, 997–1003. AOCS Publishing, 1992. http://dx.doi.org/10.1201/9781439832042.ch7.
Der volle Inhalt der QuelleGoracci, Gianfrancesco, und Ermelinda Francescangeli. „Properties of PAF-Synthesizing Phosphocholinetransferase and Evidence for LysoPAF Acetyltransferase Activity in Rat Brain“. In Platelet-Activating Factor and Structurally Related Alkyl Ehter Lipids, 986–91. AOCS Publishing, 1992. http://dx.doi.org/10.1201/9781439832042.ch5.
Der volle Inhalt der Quelle„Lysopin“. In Encyclopedia of Genetics, Genomics, Proteomics and Informatics, 1133. Dordrecht: Springer Netherlands, 2008. http://dx.doi.org/10.1007/978-1-4020-6754-9_9681.
Der volle Inhalt der Quelle„Lysova Island“. In The Eastern Arctic Seas Encyclopedia, 203. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-24237-8_315.
Der volle Inhalt der QuelleDesnick, R. J., E. H. Schuchman, K. H. Astrin und S. H. Cheng. „Enzyme Replacement and Pharmacologic Chaperone Therapies for Lysomal Storage Disease“. In Reference Module in Biomedical Sciences. Elsevier, 2014. http://dx.doi.org/10.1016/b978-0-12-801238-3.05501-x.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "LysoPAF"
Niu, Qi, Shao-Liang Peng, Xiang-Li-Lan Zhang, Shuai-Cheng Li, Ying Xu, Xiang-Cheng Xie und Yi-Gang Tong. „LysoPhD: predicting functional prophages in bacterial genomes from high-throughput sequencing“. In 2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). IEEE, 2019. http://dx.doi.org/10.1109/bibm47256.2019.8983280.
Der volle Inhalt der QuelleSugimori, Daisuke, Kiyoto Kajiyama, Shunsuke Kawashima und Yuho Matsumoto. „Phosphatidylglycerol-specific Phospholipase C from Amycolatopsis Sp. NT115: Biochemical Characterization and Heterologous Expression“. In 2022 AOCS Annual Meeting & Expo. American Oil Chemists' Society (AOCS), 2022. http://dx.doi.org/10.21748/fmmj5845.
Der volle Inhalt der Quelle